| Catalog | name | Description | price |
|---|---|---|---|
| R-R-3056 | SOS1-IN-11 CAS No.2654741-64-5 | SOS1-IN-11/CAS No.2654741-64-5 is a potent SOS1 inhibitor with an IC50 value of 30 nM. | price> |
| R-R-3057 | CMC2.24 CAS No.1255639-43-0 | CMC2.24 (TRB-N0224)/CAS No.1255639-43-0, an orally active tricarbonylmethane agent, is effective against pancreatic tumor in mice by inhibiting Ras activation and its downstream effector ERK1/2 pathway. CMC2.24 is also a potent inhibitor of zinc-dependent MMPs with IC50s ranging from 2.0-69 μM. CMC2.24 alleviates osteoarthritis progression by restoring cartilage homeostasis and inhibiting chondrocyte apoptosis via the NF-κB/HIF-2α axis. | price> |
| R-R-3058 | Kras4B G12D-IN-1 CAS No.2042365-85-3 | Kras4B G12D-IN-1/CAS No.2042365-85-3 is a Kras4B G12D inhibitor with anticancer effects. Kras4B G12D-IN-1 decreases Kras protein expression in mouse embryonic fibroblasts (MEF) expressing Kras4B G12D (WO2016179558A1, Comp 994566). | price> |
| R-R-3059 | Ketoconazole-d4 CAS No.1398065-75-2 | Ketoconazole-d4/CAS No.1398065-75-2 is the deuterium labeled Ketoconazole. Ketoconazole (R-41400) is an imidazole anti-fungal agent, a CYP3A4 and CYP24A1 inhibitor. | price> |
| R-R-3060 | Atrovastatin-PEG3-FITC CAS No.1440755-31-6 | Atrovastatin-PEG3-FITC (compound S31)/CAS No.1440755-31-6 is a KRAS-PDEδ interaction inhibitor. Atrovastatin-PEG3-FITC acts as a ligand in fluorescence anisotropy assay. | price> |
| R-R-3061 | Ketoconazole-d8 CAS No.1217706-96-1 | Ketoconazole-d8/CAS No.1217706-96-1 is the deuterium labeled Ketoconazole. Ketoconazole (R-41400) is an imidazole anti-fungal agent, a CYP3A4 and CYP24A1 inhibitor. | price> |
| R-R-3062 | Atranorin CAS No.479-20-9 | Atranorin/CAS No.479-20-9 is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1, Wnt, and STAT signaling and suppressing RhoGTPase activity. | price> |
| R-R-3063 | (S)-JDQ-443 CAS No.2653994-10-4 | (S)-JDQ-443/CAS No.2653994-10-4 is an isomer of JDQ-443 (HY-139612). JDQ-443 is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). JDQ-443 shows antitumor activity. | price> |
| R-R-3064 | Rac1-IN-3 CAS No.380470-06-4 | Rac1-IN-3 (Compound 2)/CAS No.380470-06-4 is a Rac1 inhibitor with an IC50 of 46.1 μM. | price> |
| R-R-3065 | (E/Z)-ZINC09659342 CAS No.591726-26-0 | (E/Z)-ZINC09659342/CAS No.591726-26-0 is an inhibitor of Lbc-RhoA interaction. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


